Creamy White Penile Discharge with Burning: Urethritis Until Proven Otherwise
This presentation is urethritis—most commonly from gonorrhea or chlamydia—and requires immediate empiric treatment with dual therapy covering both pathogens while awaiting test results. 1
Immediate Diagnostic Approach
The creamy white discharge strongly suggests gonococcal urethritis, which classically presents with purulent discharge, though chlamydia and other pathogens must also be considered. 1
Essential Testing
- Nucleic acid amplification tests (NAATs) for both N. gonorrhoeae and C. trachomatis on first-void urine or urethral swab—these are the preferred diagnostic modality due to superior sensitivity. 1
- Gram stain of urethral discharge if available: presence of white blood cells containing gram-negative intracellular diplococci (GNID) confirms gonococcal infection. 1
- First-void urine microscopy: ≥10 WBC per high-power field indicates urethritis. 1
- Additional STI screening: syphilis and HIV testing should be performed in all patients with confirmed STI. 1
Empiric Treatment Protocol
Treatment must be initiated immediately without waiting for test results to prevent complications and transmission. 1
Recommended Dual Therapy Regimens
- Azithromycin 1 g orally as a single dose 1
- OR Doxycycline 100 mg orally twice daily for 7 days 1
- PLUS appropriate gonorrhea coverage (Note: the 2010 guidelines predate current cephalosporin recommendations, but dual coverage for both pathogens is mandatory) 1
Key advantage of azithromycin: Single-dose therapy improves compliance and allows directly observed treatment; it also provides superior coverage for Mycoplasma genitalium, an increasingly recognized cause of urethritis. 1
Medication Dispensing
- Dispense medications on-site in the clinic when possible. 1
- Directly observe the first dose to ensure compliance. 1
Critical Management Instructions
Sexual Activity Restrictions
- Abstain from all sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen AND resolution of symptoms. 1
- Continue abstinence until all sex partners are treated to prevent reinfection. 1
Partner Management
- All sex partners within the preceding 60 days must be evaluated, tested, and empirically treated. 1
- Partners should receive treatment effective against both chlamydia and gonorrhea regardless of test results. 1
- Expedited partner therapy is an acceptable alternative approach. 1
Follow-Up Strategy
Routine Follow-Up
- Test-of-cure is NOT recommended for patients who received appropriate treatment and whose symptoms resolved. 1
- Repeat testing at 3-6 months is mandatory due to high reinfection rates (regardless of whether partners were reportedly treated). 1
Persistent or Recurrent Symptoms
- Return for evaluation only if symptoms persist or recur after completing therapy. 1
- Objective signs of urethritis must be documented before retreatment—symptoms alone are insufficient. 1
- Consider alternative diagnoses: 1
Uncommon But Critical Differential Diagnoses
While urethritis is overwhelmingly the most likely diagnosis, rare presentations warrant consideration if the clinical picture is atypical:
- Prostatic abscess: Can present with penile discharge (especially during bowel movements), though typically accompanied by systemic symptoms. 2
- Perirectal abscess with fistulous extension: Rare cause of penile discharge; requires digital rectal examination to identify fluctuant mass. 3
Perform digital rectal examination if discharge occurs specifically with defecation, if there is perineal pain, or if standard urethritis treatment fails. 2, 3
Common Pitfalls to Avoid
- Do not delay treatment waiting for test results—empiric therapy prevents complications and reduces transmission. 1
- Do not treat based on symptoms alone for recurrent cases—document objective urethritis before retreatment. 1
- Do not neglect partner treatment—untreated partners are the primary source of reinfection. 1
- Do not assume compliance—directly observed therapy significantly improves outcomes. 1